Rui-Tao Wang
Overview
Explore the profile of Rui-Tao Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
1162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jia Q, Niu Y, Xuan Q, Miao S, Huang W, Liu P, et al.
iScience
. 2024 Oct;
27(10):110733.
PMID: 39474083
We aimed to build and validate a computed tomography (CT)-based deep learning nomogram for discriminating granulomas from lung adenocarcinomas. A retrospective study of 1,159 patients with solitary lung nodules from...
2.
Song M, Zhao L, Huang W, Cui M, Liu Y, Wang R, et al.
BMC Cancer
. 2024 Aug;
24(1):1066.
PMID: 39210343
Purpose: Bone metastases occur in 50-70% of patients with breast cancer (BC) and result in high mortality. Platelet distribution width (PDW), a commonly used parameter of activated platelets, has been...
3.
Wang R, Liu H, Sun H
Chem Biol Drug Des
. 2024 Jun;
103(6):e14562.
PMID: 38898371
Docetaxel (DTX) resistance poses a significant challenge in the treatment of prostate cancer (PCa), often leading to chemotherapy failure. This study investigates the ability of piperine, a compound derived from...
4.
Sun J, Chen D, Huang R, Wang R, Jia L
World J Gastrointest Oncol
. 2024 Apr;
16(4):1500-1513.
PMID: 38660641
Background: Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies worldwide, and its development comprises a multistep process from intraepithelial neoplasia (IN) to carcinoma (CA). However, the...
5.
Liu L, Zhang B, Li Y, Huang W, Niu Y, Jia Q, et al.
Front Endocrinol (Lausanne)
. 2024 Mar;
15:1284152.
PMID: 38501103
Background: Systemic inflammation and glucose metabolism have been closely related to the survival of cancer patients. Therefore, we aimed to evaluate whether preoperative glucose-to-lymphocyte ratio (GLR) can be used to...
6.
Jia Q, Qin L, Niu Y, Liu L, Liu P, Miao S, et al.
BMC Cancer
. 2024 Jan;
24(1):95.
PMID: 38233827
Background: Sarcopenia has received increasing attention in non-small cell lung cancer (NSCLC). Red blood cell distribution width (RDW) is a significant component of the complete blood count and indicates the...
7.
Huang W, Yuan J, Zhang L, Wang W, Miao S, Wang X, et al.
Cancer Biomark
. 2023 Nov;
38(4):425-432.
PMID: 37980647
The albumin-bilirubin (ALBI) score is a novel indicator of liver function. Some studies showed that the ALBI score was a predictive marker for the prognosis and efficacy of drug therapy...
8.
Jia Q, Niu Y, Qin L, Yuan J, Liu P, Liu L, et al.
Clin Nutr
. 2023 Aug;
42(10):1932-1939.
PMID: 37634307
Background: Postoperative skeletal muscle loss (SM loss) was reported to be associated with a poor prognosis in early-stage non-small cell lung cancer (NSCLC). Small airway dysfunction (SAD) is a common...
9.
Wang W, Huang W, Liu P, Fu S, Zhang M, Zhang X, et al.
Cancer Biomark
. 2023 Aug;
38(1):121-130.
PMID: 37545220
Background: Bone metastases affect 50% to 70% of breast cancer (BC) patients and have a high mortality rate. Adipose tissue loss plays a pivotal role in the progression of cancer....
10.
Zhu W, Wang H, Guan Q, Zhang F, Zhang C, Hu F, et al.
World J Gastrointest Surg
. 2023 May;
15(4):674-686.
PMID: 37206073
Background: Pancreaticoduodenectomy combined with portal vein (PV) and/or superior mesenteric vein (SMV) resection in patients with pancreaticobiliary malignancy has become a common surgical procedure. There are various grafts currently used...